CNS Spectrums

Aims & Scope

CNS Spectrums covers all aspects of the clinical neurosciences, neurotherapeutics, and neuropsychopharmacology, particularly those pertinent to the clinician and clinical investigator.

The journal features focused, in-depth reviews, perspectives, and original research articles.

New therapeutics of all types in psychiatry, mental health, and neurology are emphasized, especially first in man studies, proof of concept studies, and translational basic neuroscience studies.

Subject coverage spans the full spectrum of neuropsychiatry, focusing on those crossing traditional boundaries between neurology and psychiatry.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.1
2024	3.40

SJR (SCImago Journal Rank)

Year	Value
2024	1.095

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	94

Journal Rank

Year	Value
2024	4168

Journal Citation Indicator

Year	Value
2024	920

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Subgenual Anterior Cingulate Cortex in Mood Disorders

  Citation: 908

  Authors: Wayne C., Jonathan, Michael

• Mild Cognitive Impairment:<i>An Overview</i>

  Citation: 506

  Authors: Ronald C., Selamawit

• Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects

  Citation: 416

  Authors: Michael, Jiuan Su

• State of the science on mild cognitive impairment (MCI)

  Citation: 409

  Authors: Nicole D.

• New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity

  Citation: 365

  Authors: Naomi A, Samuel R., Anna E., Dan J., Louk J. M. J., Claire M., Sameer, Philip A. P. M., Valerie, Sharon, Damiaan, Barbara J., F. Gerard, Trevor W., Marc N.

• SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

  Citation: 345

  Authors: Stephen M., Meghan M., Chantal, Mike

• The Prevalence of Body Dysmorphic Disorder in the United States Adult Population

  Citation: 342

  Authors: Lorrin M., Elias, Michael D., Richard T.

• The role of reproductive hormones in postpartum depression

  Citation: 337

  Authors: Crystal Edler, Samantha, David R.

• The neurobiology of aggression and violence

  Citation: 328

  Authors: Daniel R., Larry J.

• Functional Neuroimaging Studies of Human Emotions

  Citation: 327

  Authors: K. Luan, Tor D., Stephan F., Israel

---